Literature DB >> 17217051

TRPC3: a multifunctional, pore-forming signalling molecule.

P Eder1, M Poteser, K Groschner.   

Abstract

TRPC3 represents one of the first identified mammalian relatives of the Drosophila trp gene product. Despite intensive biochemical and biophysical characterization as well as numerous attempts to uncover its physiological role in native cell systems, this channel protein still represents one of the most enigmatic members of the transient receptor potential (TRP) superfamily. TRPC3 is significantly expressed in brain and heart and likely to play a role in both non-excitable as well as excitable cells, being potentially involved in a wide spectrum of Ca2+ signalling mechanisms. Its ability to associate with a variety of partner proteins apparently enables TRPC3 to form different cation channels in native cells. TRPC3 cation channels display unique gating and regulatory properties that allow for recognition and integration of multiple input stimuli including lipid mediators and cellular Ca2+ gradients as well as redox signals. The physiological/pathophysiological functions of this highly versatile cation channel protein are as yet barely delineated. Here we summarize current knowledge on properties and possible signalling functions of TRPC3 and discuss the potential biological relevance of this signalling molecule.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17217051     DOI: 10.1007/978-3-540-34891-7_4

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  10 in total

Review 1.  Intrinsic and integrative properties of substantia nigra pars reticulata neurons.

Authors:  F-M Zhou; C R Lee
Journal:  Neuroscience       Date:  2011-08-02       Impact factor: 3.590

Review 2.  TRP channels entering the structural era.

Authors:  Rachelle Gaudet
Journal:  J Physiol       Date:  2008-06-05       Impact factor: 5.182

3.  Location and function of transient receptor potential canonical channel 1 in ventricular myocytes.

Authors:  Qinghua Hu; Azmi A Ahmad; Thomas Seidel; Chris Hunter; Molly Streiff; Linda Nikolova; Kenneth W Spitzer; Frank B Sachse
Journal:  J Mol Cell Cardiol       Date:  2020-01-23       Impact factor: 5.000

4.  TRPC3 activation by erythropoietin is modulated by TRPC6.

Authors:  Iwona Hirschler-Laszkiewicz; Qin Tong; Kathleen Conrad; Wenyi Zhang; Wesley W Flint; Alistair J Barber; Dwayne L Barber; Joseph Y Cheung; Barbara A Miller
Journal:  J Biol Chem       Date:  2008-12-13       Impact factor: 5.157

5.  The puzzling role of TRPC3 channels in motor coordination.

Authors:  Mohamed Trebak
Journal:  Pflugers Arch       Date:  2009-10-14       Impact factor: 3.657

Review 6.  Pharmacological modulation of diacylglycerol-sensitive TRPC3/6/7 channels.

Authors:  Christian Harteneck; Maik Gollasch
Journal:  Curr Pharm Biotechnol       Date:  2011-01-01       Impact factor: 2.837

7.  Reduction of blood pressure by store-operated calcium channel blockers.

Authors:  Yan-Jun Xu; Vijayan Elimban; Naranjan S Dhalla
Journal:  J Cell Mol Med       Date:  2015-10-16       Impact factor: 5.310

Review 8.  The Moonwalker mouse: new insights into TRPC3 function, cerebellar development, and ataxia.

Authors:  Esther B E Becker
Journal:  Cerebellum       Date:  2014-10       Impact factor: 3.847

9.  Subcutaneous white adipocytes express a light sensitive signaling pathway mediated via a melanopsin/TRPC channel axis.

Authors:  Katarina Ondrusova; Mohammad Fatehi; Amy Barr; Zofia Czarnecka; Wentong Long; Kunimasa Suzuki; Scott Campbell; Koenraad Philippaert; Matthew Hubert; Edward Tredget; Peter Kwan; Nicolas Touret; Martin Wabitsch; Kevin Y Lee; Peter E Light
Journal:  Sci Rep       Date:  2017-11-27       Impact factor: 4.379

10.  A point mutation in TRPC3 causes abnormal Purkinje cell development and cerebellar ataxia in moonwalker mice.

Authors:  Esther B E Becker; Peter L Oliver; Maike D Glitsch; Gareth T Banks; Francesca Achilli; Andrea Hardy; Patrick M Nolan; Elizabeth M C Fisher; Kay E Davies
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-07       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.